Naproxen
(CDBRNDSHEYLDJV-FVGYRXGTSA-M)
Structure
- SMILES
- COc1ccc2c(c1)ccc(c2)[C@@H](C(=O)[O-])C.[Na+]
- Molecular Formula:
- C14H13NaO3
- Molecular Weight:
- 252.241
- Log P:
- 1.7018
- Hydrogen Bond Acceptor:
- 3
- Hydrogen Bond Donor:
- 0
- TPSA:
- 49.36
- CAS Number(s):
- 26159-34-2
Synonym(s)
1.
Naproxen
2.
Aleve
3.
Anaprox
4.
Methoxypropiocin
5.
Naprosin
6.
Naprosyn
7.
Naproxen Sodium
8.
Proxen
9.
Sodium Naproxenate
10.
Synflex
11.
Naproxenate, Sodium
12.
Sodium, Naproxen
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | No adverse event | FAERS: 259 | US FAERS | |
| 2 | Drug ineffective | FAERS: 152 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 3 | Headache | FAERS: 91 | US FAERS | |
| 4 | Pain | FAERS: 45 | US FAERS | |
| 5 | Expired product administered | FAERS: 43 | US FAERS | |
| 6 | Nausea | FAERS: 41 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 7 | Hypersensitivity | FAERS: 39 | US FAERS | |
| 8 | Incorrect dose administered | FAERS: 35 | US FAERS | |
| 9 | Urticaria | FAERS: 34 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 10 | Vomiting | FAERS: 33 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 11 | Dizziness | FAERS: 32 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 12 | Feeling abnormal | FAERS: 32 | US FAERS | |
| 13 | Somnolence | FAERS: 26 | US FAERS | |
| 14 | Abdominal discomfort | FAERS: 22 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 15 | Incorrect drug administration duration | FAERS: 22 | US FAERS | |
| 16 | Pruritus | FAERS: 22 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 17 | Malaise | FAERS: 21 | US FAERS | |
| 18 | Chest Pain | FAERS: 20 | US FAERS | |
| 19 | Back Pain | FAERS: 19 | US FAERS | |
| 20 | Overdose | FAERS: 19 | US FAERS | |
| 21 | Arthralgia | FAERS: 15 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 22 | Euphoric mood | FAERS: 15 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 23 | Erythema | FAERS: 14 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 24 | Abdominal Pain | FAERS: 13 | US FAERS | |
| 25 | Dyspepsia | FAERS: 11 | US FAERS | |
| 26 | Fatigue | FAERS: 11 | US FAERS | |
| 27 | Gastric ulcer | FAERS: 11 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 28 | Syncope | FAERS: 10 | US FAERS | |
| 29 | Anxiety | FAERS: 9 | US FAERS | |
| 30 | Asthenia | FAERS: 9 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 31 | Angioedema | FAERS: 8 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 32 | Burning sensation | FAERS: 8 | US FAERS | |
| 33 | Drug Dependence | FAERS: 8 | US FAERS | |
| 34 | Drug exposure during pregnancy | FAERS: 8 | US FAERS | |
| 35 | Inappropriate schedule of drug administration | FAERS: 8 | US FAERS | |
| 36 | Kounis Syndrome | FAERS: 8 | US FAERS | |
| 37 | Palpitations | FAERS: 8 | US FAERS | |
| 38 | Tremor | FAERS: 8 | US FAERS | |
| 39 | Agitation | FAERS: 7 | US FAERS | |
| 40 | Choking | FAERS: 7 | US FAERS | |
| 41 | Constipation | FAERS: 7 | US FAERS | |
| 42 | Peripheral swelling | FAERS: 7 | US FAERS | |
| 43 | Poor quality drug administered | FAERS: 7 | US FAERS | |
| 44 | Product quality issue | FAERS: 7 | US FAERS | |
| 45 | Swelling | FAERS: 7 | US FAERS | |
| 46 | Throat irritation | FAERS: 7 | US FAERS | |
| 47 | Wrong technique in product usage process | FAERS: 7 | US FAERS | |
| 48 | Cerebrovascular accident | FAERS: 6 | US FAERS | |
| 49 | Drug screen positive | FAERS: 6 | US FAERS | |
| 50 | Dysgeusia | FAERS: 6 | US FAERS | |
| 51 | Feeling jittery | FAERS: 6 | US FAERS | |
| 52 | Lip swelling | FAERS: 6 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 53 | Oligohydramnios | FAERS: 6 | US FAERS | |
| 54 | Pharmaceutical product complaint | FAERS: 6 | US FAERS | |
| 55 | Product substitution issue | FAERS: 6 | US FAERS | |
| 56 | Therapeutic product ineffective | FAERS: 6 | US FAERS | |
| 57 | Drug effect incomplete | FAERS: 5 | US FAERS | |
| 58 | Epistaxis | FAERS: 5 | US FAERS | |
| 59 | Hypotension | FAERS: 5 | US FAERS | |
| 60 | Ileitis | FAERS: 5 | US FAERS | |
| 61 | Intestinal Perforation | FAERS: 5 | US FAERS | |
| 62 | Myocardial Infarction | FAERS: 5 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 63 | Oropharyngeal pain | FAERS: 5 | US FAERS | |
| 64 | Product taste abnormal | FAERS: 5 | US FAERS | |
| 65 | Toothache | FAERS: 5 | US FAERS | |
| 66 | Wrong drug administered | FAERS: 5 | US FAERS | |
| 67 | Anaphylactic shock | FAERS: 4 | US FAERS | |
| 68 | Chills | FAERS: 4 | US FAERS | |
| 69 | Disorientation | FAERS: 4 | US FAERS | |
| 70 | Duodenal Ulcer | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 71 | Dysarthria | FAERS: 4 | US FAERS | |
| 72 | Incorrect product administration duration | FAERS: 4 | US FAERS | |
| 73 | Musculoskeletal Pain | FAERS: 4 | US FAERS | |
| 74 | Nervousness | FAERS: 4 | US FAERS | |
| 75 | Optic Neuritis | FAERS: 4 | US FAERS | |
| 76 | Product physical consistency issue | FAERS: 4 | US FAERS | |
| 77 | Product physical issue | FAERS: 4 | US FAERS | |
| 78 | Rash erythematous | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 79 | Stomatitis | FAERS: 4 | US FAERS | |
| 80 | Tachycardia | FAERS: 4 | US FAERS | |
| 81 | Weight decreased | FAERS: 4 | US FAERS | |
| 82 | Accidental exposure | FAERS: 3 | US FAERS | |
| 83 | Atrioventricular Septal Defect | FAERS: 3 | US FAERS | |
| 84 | Candidiasis | FAERS: 3 | US FAERS | |
| 85 | Chest discomfort | FAERS: 3 | US FAERS | |
| 86 | Disseminated Intravascular Coagulation | FAERS: 3 | US FAERS | |
| 87 | Drug effect delayed | FAERS: 3 | US FAERS | |
| 88 | Electrolyte imbalance | FAERS: 3 | US FAERS | |
| 89 | Extra dose administered | FAERS: 3 | US FAERS | |
| 90 | Glossitis | FAERS: 3 | US FAERS | |
| 91 | Joint swelling | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 92 | Leukocytoclastic vasculitis | FAERS: 3 | US FAERS | |
| 93 | Metabolic acidosis | FAERS: 3 | US FAERS | |
| 94 | Oropharyngeal blistering | FAERS: 3 | US FAERS | |
| 95 | Oropharyngeal discomfort | FAERS: 3 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 96 | Pallor | FAERS: 3 | US FAERS | |
| 97 | Peritoneal Dialysis | FAERS: 3 | US FAERS | |
| 98 | Pneumonia | FAERS: 3 | US FAERS | |
| 99 | Product commingling | FAERS: 3 | US FAERS | |
| 100 | Self-induced vomiting | FAERS: 3 | US FAERS | |
| 101 | Sepsis | FAERS: 3 | US FAERS | |
| 102 | Suicide attempt | FAERS: 3 | US FAERS | |
| 103 | Therapeutic response unexpected with drug substitution | FAERS: 3 | US FAERS | |
| 104 | Tinnitus | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 105 | Toxicity to various agents | FAERS: 3 | US FAERS | |
| 106 | Unevaluable event | FAERS: 3 | US FAERS | |
| 107 | Vasculitis | FAERS: 3 | US FAERS | |
| 108 | Vulvovaginal discomfort | FAERS: 3 | US FAERS | |
| 109 | Vulvovaginal swelling | FAERS: 3 | US FAERS | |
| 110 | Wheezing | FAERS: 3 | US FAERS | |
| 111 | Abasia | FAERS: 2 | US FAERS | |
| 112 | Accidental exposure to product | FAERS: 2 | US FAERS | |
| 113 | Accidental exposure to product by child | FAERS: 2 | US FAERS | |
| 114 | Accidental overdose | FAERS: 2 | US FAERS | |
| 115 | Acute myocardial infarction | FAERS: 2 | US FAERS | |
| 116 | Adverse event | FAERS: 2 | US FAERS | |
| 117 | Alopecia | FAERS: 2 | US FAERS | |
| 118 | Amnesia | FAERS: 2 | US FAERS | |
| 119 | Anuria | FAERS: 2 | US FAERS | |
| 120 | Arthritis | FAERS: 2 | US FAERS | |
| 121 | Atrial Fibrillation | FAERS: 2 | US FAERS | |
| 122 | Blood potassium increased | FAERS: 2 | US FAERS | |
| 123 | Blood sodium decreased | FAERS: 2 | US FAERS | |
| 124 | Blood urine present | FAERS: 2 | US FAERS | |
| 125 | Cardiac Arrest | FAERS: 2 | US FAERS | |
| 126 | Cardiomegaly | FAERS: 2 | US FAERS | |
| 127 | Chromaturia | FAERS: 2 | US FAERS | |
| 128 | Disseminated intravascular coagulation in newborn | FAERS: 2 | US FAERS | |
| 129 | Diverticulitis | FAERS: 2 | US FAERS | |
| 130 | Drug administered to patient of inappropriate age | FAERS: 2 | US FAERS | |
| 131 | Drug administration error | FAERS: 2 | US FAERS | |
| 132 | Drug ineffective for unapproved indication | FAERS: 2 | US FAERS | |
| 133 | Drug screen false positive | FAERS: 2 | US FAERS | |
| 134 | Dysphonia | FAERS: 2 | US FAERS | |
| 135 | Expired drug administered | FAERS: 2 | US FAERS | |
| 136 | Flatulence | FAERS: 2 | US FAERS | |
| 137 | Flushing | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 138 | Gastritis | FAERS: 2 | US FAERS | |
| 139 | Histiocytosis haematophagic | FAERS: 2 | US FAERS | |
| 140 | Hypersomnia | FAERS: 2 | US FAERS | |
| 141 | Impaired work ability | FAERS: 2 | US FAERS | |
| 142 | Inappropriate affect | FAERS: 2 | US FAERS | |
| 143 | Incorrect product storage | FAERS: 2 | US FAERS | |
| 144 | Medication Error | FAERS: 2 | US FAERS | |
| 145 | Musculoskeletal stiffness | FAERS: 2 | US FAERS | |
| 146 | Myalgia | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 147 | Neck Pain | FAERS: 2 | US FAERS | |
| 148 | Neonatal anuria | FAERS: 2 | US FAERS | |
| 149 | Neonatal disorder | FAERS: 2 | US FAERS | |
| 150 | Pelvic Pain | FAERS: 2 | US FAERS | |
| 151 | Petechiae | FAERS: 2 | US FAERS | |
| 152 | Product leakage | FAERS: 2 | US FAERS | |
| 153 | Product use in unapproved indication | FAERS: 2 | US FAERS | |
| 154 | Product use issue | FAERS: 2 | US FAERS | |
| 155 | Pseudoporphyria | FAERS: 2 | US FAERS | |
| 156 | Renal tubular disorder | FAERS: 2 | US FAERS | |
| 157 | Restless Legs Syndrome | FAERS: 2 | US FAERS | |
| 158 | Restlessness | FAERS: 2 | US FAERS | |
| 159 | Shock | FAERS: 2 | US FAERS | |
| 160 | Sinus Tachycardia | FAERS: 2 | US FAERS | |
| 161 | Therapeutic response delayed | FAERS: 2 | US FAERS | |
| 162 | Thrombocytopenia | FAERS: 2 | US FAERS | |
| 163 | Tongue discomfort | FAERS: 2 | US FAERS | |
| 164 | Toxic Epidermal Necrolysis | FAERS: 2 | US FAERS | |
| 165 | Ulcer | FAERS: 2 | US FAERS | |
| 166 | Upper airway obstruction | FAERS: 2 | US FAERS | |
| 167 | Urinary tract infection | FAERS: 2 | US FAERS | |
| 168 | Vertigo | FAERS: 2 | US FAERS | |
| 169 | Accidental death | FAERS: 1 | US FAERS | |
| 170 | Accidental drug intake by child | FAERS: 1 | US FAERS | |
| 171 | Acne | FAERS: 1 | US FAERS | |
| 172 | Alanine Aminotransferase Increased | FAERS: 1 | US FAERS | |
| 173 | Anaphylactoid Reaction | FAERS: 1 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 174 | Anger | FAERS: 1 | US FAERS | |
| 175 | Aphonia | FAERS: 1 | US FAERS | |
| 176 | Apparent death | FAERS: 1 | US FAERS | |
| 177 | Ascites | FAERS: 1 | US FAERS | |
| 178 | Aspartate Aminotransferase Increased | FAERS: 1 | US FAERS | |
| 179 | Asthenopia | FAERS: 1 | US FAERS | |
| 180 | Asthma | FAERS: 1 | US FAERS | |
| 181 | Atrioventricular Block | FAERS: 1 | US FAERS | |
| 182 | Blood alkaline phosphatase increased | FAERS: 1 | US FAERS | |
| 183 | Blood creatine phosphokinase MB increased | FAERS: 1 | US FAERS | |
| 184 | Blood creatine phosphokinase increased | FAERS: 1 | US FAERS | |
| 185 | Blood creatinine increased | FAERS: 1 | US FAERS | |
| 186 | Blood glucose increased | FAERS: 1 | US FAERS | |
| 187 | Blood urea increased | FAERS: 1 | US FAERS | |
| 188 | Bradycardia | FAERS: 1 | US FAERS | |
| 189 | Bruxism | FAERS: 1 | US FAERS | |
| 190 | Cachexia | FAERS: 1 | US FAERS | |
| 191 | Candida sepsis | FAERS: 1 | US FAERS | |
| 192 | Cardiac discomfort | FAERS: 1 | US FAERS | |
| 193 | Cerebral Arteriosclerosis | FAERS: 1 | US FAERS | |
| 194 | Cholelithiasis | FAERS: 1 | US FAERS | |
| 195 | Cleft Palate | FAERS: 1 | US FAERS | |
| 196 | Colitis | FAERS: 1 | US FAERS | |
| 197 | Colonic Stenosis | FAERS: 1 | US FAERS | |
| 198 | Deformity | FAERS: 1 | US FAERS | |
| 199 | Dehydration | FAERS: 1 | US FAERS | |
| 200 | Delirium | FAERS: 1 | US FAERS | |
| 201 | Dermo-hypodermitis | FAERS: 1 | US FAERS | |
| 202 | Disability | FAERS: 1 | US FAERS | |
| 203 | Discomfort | FAERS: 1 | US FAERS | |
| 204 | Diverticulum | FAERS: 1 | US FAERS | |
| 205 | Drooling | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 206 | Drug abuser | FAERS: 1 | US FAERS | |
| 207 | Drug effect variable | FAERS: 1 | US FAERS | |
| 208 | Drug level above therapeutic | FAERS: 1 | US FAERS | |
| 209 | Duodenal perforation | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 210 | Economic problem | FAERS: 1 | US FAERS | |
| 211 | Endotracheal intubation complication | FAERS: 1 | US FAERS | |
| 212 | Eosinophilia | FAERS: 1 | US FAERS | |
| 213 | Erosive Duodenitis | FAERS: 1 | US FAERS | |
| 214 | Erythema Multiforme | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 215 | Erythema Nodosum | FAERS: 1 | US FAERS | |
| 216 | Eye pain | FAERS: 1 | US FAERS | |
| 217 | Eyelid irritation | FAERS: 1 | US FAERS | |
| 218 | Facial Paresis | FAERS: 1 | US FAERS | |
| 219 | Fibromyalgia | FAERS: 1 | US FAERS | |
| 220 | Fixed drug eruption | FAERS: 1 | US FAERS | |
| 221 | Foaming at mouth | FAERS: 1 | US FAERS | |
| 222 | Food Allergy | FAERS: 1 | US FAERS | |
| 223 | Gangrene | FAERS: 1 | US FAERS | |
| 224 | Gastric Fistula | FAERS: 1 | US FAERS | |
| 225 | Gastrointestinal Pain | FAERS: 1 | US FAERS | |
| 226 | Gastrointestinal infection | FAERS: 1 | US FAERS | |
| 227 | Gastrointestinal inflammation | FAERS: 1 | US FAERS | |
| 228 | Gastrointestinal ulcer | FAERS: 1 | US FAERS | |
| 229 | Granuloma | FAERS: 1 | US FAERS | |
| 230 | Hepatitis | FAERS: 1 | US FAERS | |
| 231 | Hepatosplenomegaly | FAERS: 1 | US FAERS | |
| 232 | Hunger | FAERS: 1 | US FAERS | |
| 233 | Hydronephrosis | FAERS: 1 | US FAERS | |
| 234 | Hypoaesthesia facial | FAERS: 1 | US FAERS | |
| 235 | Impaired self-care | FAERS: 1 | US FAERS | |
| 236 | Inappropriate schedule of product administration | FAERS: 1 | US FAERS | |
| 237 | Incoherent | FAERS: 1 | US FAERS | |
| 238 | Incorrect drug dosage form administered | FAERS: 1 | US FAERS | |
| 239 | Increased upper airway secretion | FAERS: 1 | US FAERS | |
| 240 | Inflammation | FAERS: 1 | US FAERS | |
| 241 | Influenza | FAERS: 1 | US FAERS | |
| 242 | Injury asphyxiation | FAERS: 1 | US FAERS | |
| 243 | Intentional product misuse | FAERS: 1 | US FAERS | |
| 244 | Intercepted product dispensing error | FAERS: 1 | US FAERS | |
| 245 | Joint Range of Motion Decreased | FAERS: 1 | US FAERS | |
| 246 | Joint stiffness | FAERS: 1 | US FAERS | |
| 247 | Labyrinthitis | FAERS: 1 | US FAERS | |
| 248 | Laziness | FAERS: 1 | US FAERS | |
| 249 | Lethargy | FAERS: 1 | US FAERS | |
| 250 | Leukocytosis | FAERS: 1 | US FAERS | |
| 251 | Leukopenia | FAERS: 1 | US FAERS | |
| 252 | Limb injury | FAERS: 1 | US FAERS | |
| 253 | Lipoma | FAERS: 1 | US FAERS | |
| 254 | Lymphadenopathy | FAERS: 1 | US FAERS | |
| 255 | Maternal exposure during pregnancy | FAERS: 1 | US FAERS | |
| 256 | Memory impairment | FAERS: 1 | US FAERS | |
| 257 | Meningism | FAERS: 1 | US FAERS | |
| 258 | Mental impairment | FAERS: 1 | US FAERS | |
| 259 | Middle insomnia | FAERS: 1 | US FAERS | |
| 260 | Muscle strain | FAERS: 1 | US FAERS | |
| 261 | Myoglobin blood increased | FAERS: 1 | US FAERS | |
| 262 | Neutropenia | FAERS: 1 | US FAERS | |
| 263 | No reaction on previous exposure to drug | FAERS: 1 | US FAERS | |
| 264 | Non-cardiac chest pain | FAERS: 1 | US FAERS | |
| 265 | Noninfective gingivitis | FAERS: 1 | US FAERS | |
| 266 | Ocular discomfort | FAERS: 1 | US FAERS | |
| 267 | Oliguria | FAERS: 1 | US FAERS | |
| 268 | Oral pain | FAERS: 1 | US FAERS | |
| 269 | Oropharyngeal swelling | FAERS: 1 | US FAERS | |
| 270 | Osteomyelitis | FAERS: 1 | US FAERS | |
| 271 | Peritoneal candidiasis | FAERS: 1 | US FAERS | |
| 272 | Peritoneal fluid analysis abnormal | FAERS: 1 | US FAERS | |
| 273 | Peritonitis | FAERS: 1 | US FAERS | |
| 274 | Pharyngitis | FAERS: 1 | US FAERS | |
| 275 | Physical examination abnormal | FAERS: 1 | US FAERS | |
| 276 | Poisoning | FAERS: 1 | US FAERS | |
| 277 | Post procedural complication | FAERS: 1 | US FAERS | |
| 278 | Procedural complication | FAERS: 1 | US FAERS | |
| 279 | Product adhesion issue | FAERS: 1 | US FAERS | |
| 280 | Product coating issue | FAERS: 1 | US FAERS | |
| 281 | Product contamination physical | FAERS: 1 | US FAERS | |
| 282 | Product label issue | FAERS: 1 | US FAERS | |
| 283 | Product size issue | FAERS: 1 | US FAERS | |
| 284 | Prolonged expiration | FAERS: 1 | US FAERS | |
| 285 | Pulmonary Embolism | FAERS: 1 | US FAERS | |
| 286 | Reaction to drug excipients | FAERS: 1 | US FAERS | |
| 287 | Renal Cell Carcinoma | FAERS: 1 | US FAERS | |
| 288 | Renal dysplasia | FAERS: 1 | US FAERS | |
| 289 | Renin increased | FAERS: 1 | US FAERS | |
| 290 | Respiratory Failure | FAERS: 1 | US FAERS | |
| 291 | Respiratory arrest | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 292 | Sciatica | FAERS: 1 | US FAERS | |
| 293 | Sneezing | FAERS: 1 | US FAERS | |
| 294 | Status Asthmaticus | FAERS: 1 | US FAERS | |
| 295 | Stevens-Johnson Syndrome | FAERS: 1 | US FAERS | |
| 296 | Stress | FAERS: 1 | US FAERS | |
| 297 | Stridor | FAERS: 1 | US FAERS | |
| 298 | Sudden onset of sleep | FAERS: 1 | US FAERS | |
| 299 | Synovial Cyst | FAERS: 1 | US FAERS | |
| 300 | Therapeutic reaction time decreased | FAERS: 1 | US FAERS | |
| 301 | Therapeutic response unexpected | FAERS: 1 | US FAERS | |
| 302 | Therapy non-responder | FAERS: 1 | US FAERS | |
| 303 | Thermal burn | FAERS: 1 | US FAERS | |
| 304 | Thirst | FAERS: 1 | US FAERS | |
| 305 | Thrombosis | FAERS: 1 | US FAERS | |
| 306 | Tooth Infection | FAERS: 1 | US FAERS | |
| 307 | Troponin I increased | FAERS: 1 | US FAERS | |
| 308 | Uterine Rupture | FAERS: 1 | US FAERS | |
| 309 | Uterine spasm | FAERS: 1 | US FAERS | |
| 310 | Ventricular hypertrophy | FAERS: 1 | US FAERS | |
| 311 | Visual Impairment | FAERS: 1 | US FAERS | |
| 312 | Wrong product administered | FAERS: 1 | US FAERS | |
| 313 | Wrong technique in drug usage process | FAERS: 1 | US FAERS | |
| 314 | jaundice | FAERS: 1 | US FAERS | |
| 315 | treatment failure | FAERS: 1 | US FAERS | |
| 316 | Peptic Ulcer | Canada Vigilance: 1 | Canada Vigilance | |
| 317 | Product complaint | Canada Vigilance: 1 | Canada Vigilance | |
| 318 | Rheumatoid Arthritis | Canada Vigilance: 1 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.